Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 111 entries
View as:

A Study to Evaluate the Efficacy and Safety of DA-5204

Phase: N/A Priority: Normal
NCT ID: NCT02282670 Org: User:
Start: 04/30/14 End: 11/30/14 Due: 11/30/15

BE Study of Gaster®D Tab 20mg (Manufacturer Changed)

Phase: N/A Priority: Normal
NCT ID: NCT04123899 Org: User:
Start: 10/11/19 End: 01/03/20 Due: 01/03/21

Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT06151210 Org: User:
Start: 01/31/24 End: 12/31/24 Due: 12/31/25

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03343145 Org: User:
Start: 01/12/17 End: 07/29/19 Due: 07/29/20

Phase I Clinical Trial of DA-6886 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01633723 Org: User:
Start: 08/31/12 End: 04/30/14 Due: 04/30/15

Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT02967939 Org: User:
Start: 03/28/17 End: 07/15/19 Due: 07/15/20

To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)

Phase: N/A Priority: Normal
NCT ID: NCT03521713 Org: User:
Start: 03/01/16 End: 03/31/21 Due: 03/31/22

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05106205 Org: User:
Start: 12/21/21 End: 01/20/22 Due: 01/20/23

Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02780323 Org: User:
Start: 11/02/15 End: 12/26/17 Due: 12/26/18

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Phase: N/A Priority: Normal
NCT ID: NCT02954822 Org: User:
Start: 11/14/16 End: 08/09/17 Due: 08/09/18

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02963389 Org: User:
Start: 10/04/16 End: 11/30/18 Due: 11/30/19

A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601

Phase: N/A Priority: Normal
NCT ID: NCT01912066 Org: User:
Start: 09/30/12 End: 03/31/14 Due: 03/31/15

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Phase: N/A Priority: Normal
NCT ID: NCT06290349 Org: User:
Start: 02/28/24 End: 11/30/25 Due: 11/30/26

A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03061981 Org: User:
Start: 03/29/17 End: 10/11/17 Due: 10/11/18

To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02580006 Org: User:
Start: 11/30/15 End: 03/31/16 Due: 03/31/17

A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

Phase: N/A Priority: Normal
NCT ID: NCT01820728 Org: User:
Start: 01/31/07 End: 10/31/12 Due: 10/31/13

Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab"

Phase: N/A Priority: Normal
NCT ID: NCT03932435 Org: User:
Start: 04/23/19 End: 05/28/19 Due: 05/28/20

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02955706 Org: User:
Start: 04/01/16 End: 01/25/19 Due: 01/25/20

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04195919 Org: User:
Start: 07/10/20 End: 05/24/21 Due: 05/24/22

Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT02824380 Org: User:
Start: 07/31/16 End: 10/31/16 Due: 10/31/17

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

Phase: N/A Priority: Normal
NCT ID: NCT05739851 Org: User:
Start: 03/18/23 End: 04/14/23 Due: 04/14/24

Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Phase: N/A Priority: Normal
NCT ID: NCT03766724 Org: User:
Start: 11/22/18 End: 01/18/19 Due: 01/18/20

Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02280590 Org: User:
Start: 09/30/14 End: - Due: -

Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02557594 Org: User:
Start: 10/06/15 End: 03/08/16 Due: 03/08/17

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01670357 Org: User:
Start: 04/30/12 End: 03/31/13 Due: 03/31/14